These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3482504)

  • 1. [Synthesis and radioprotective activity of beta-(3-indazolyl)-ethylamine derivatives].
    Rao EC; Li MJ; Wang RX; Zhuang XL
    Yao Xue Xue Bao; 1987 Jun; 22(6):426-32. PubMed ID: 3482504
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioprotective activity of some beta-hydroxylated indole-alkylamines.
    Deanović Z; Trescec A; Kveder S; Iskrić S; Supek Z
    Strahlentherapie; 1982 Jun; 158(6):375-7. PubMed ID: 6750860
    [No Abstract]   [Full Text] [Related]  

  • 3. [Radioprotective effectiveness and toxicity of 4,5-disubstituted tryptamines].
    Korovkina EP; Chernov GA; Vinograd LKh; Petrunin IA; Suvorov NN
    Radiobiologiia; 1986; 26(6):833-6. PubMed ID: 3468557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on synthesis and chemical structure-radioprotective activity correlation of thiazolidines].
    Hu B; Zhong DF; Huang R; Li MJ; Li SZ; Song XY; Tang WC; Zhang CZ; Song YL; Fang LF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Feb; 7(1):6-14. PubMed ID: 3158420
    [No Abstract]   [Full Text] [Related]  

  • 5. Increase of radioprotective potency of 5-methoxytryptamine by means of calcium.
    Pospisil M; Netíková J
    Radiobiol Radiother (Berl); 1974; 15(4):521-4. PubMed ID: 4531650
    [No Abstract]   [Full Text] [Related]  

  • 6. The oxygen consumption values during irradiation as an index of the radioprotective action of 5-methoxytryptamine.
    Misustová J; Novák L; Hosek B; Kautská J
    Radiobiol Radiother (Berl); 1974; 15(4):487-91. PubMed ID: 4531649
    [No Abstract]   [Full Text] [Related]  

  • 7. [Search for new radioprotective agents. XXIX. Synthesis of some 2-quinoxaline sulfide derivatives].
    Tulecki J; Kalinowska-Torz J; Janowska B
    Acta Pol Pharm; 1974; 31(4):463-7. PubMed ID: 4423671
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential radioprotective agents. 1. Homologs of melatonin.
    Blickenstaff RT; Brandstadter SM; Reddy S; Witt R
    J Pharm Sci; 1994 Feb; 83(2):216-8. PubMed ID: 8169792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in the therapeutic spectrum with respect to the pharmacological and radioprotective activity after O-alkylation of serotonin and 5(2-hydroxyethoxytryptamine)].
    Vasin MV; Suvorov NN; Abramov MM; Gordeev EN
    Radiobiologiia; 1987; 27(5):700-3. PubMed ID: 3478752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trans-1-(4-phenylcyclohexyl)ethylamine derivatives with antidepressant activity. II].
    Carenini G; de Meglio P; Gentili P; Manzardo S
    Farmaco Sci; 1987 Nov; 42(11):861-71. PubMed ID: 3502091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological potentiation of the radioprotective action of hypoxic hypoxia].
    Ovakimov VG; Iarmonenko SP; Klimova TS
    Radiobiologiia; 1974; 14(6):859-63. PubMed ID: 4532268
    [No Abstract]   [Full Text] [Related]  

  • 12. [Monoamine oxidase inhibitors. I. Synthesis of N-cyclopropyltryptamines].
    Chimenti F; Casanova MC; Turini P; Sabatini S
    Farmaco Sci; 1980 Sep; 35(9):785-90. PubMed ID: 6935082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total and local hemodynamic changes in rats following intramuscular administration of a radioprotective mixture of cystamine and mexamine.
    Kuna P; Volenec K; Dostál M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1982; 25(1):105-12. PubMed ID: 6983107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Radioprotective effect of cystamine and mexamine in 2 sequential cell divisions].
    Sidorov VP
    Radiobiologiia; 1981; 21(3):368-73. PubMed ID: 6945628
    [No Abstract]   [Full Text] [Related]  

  • 15. [Decrease in radioprotective activity with simultaneous intragastric administration of cystamine and 5-methoxytryptamine].
    Davydov BI; Kozlov VA
    Radiobiologiia; 1973; 13(1):127-9. PubMed ID: 4719874
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of the radioprotective action of mexamine based on the cellularity index of the rat thymus].
    Kormer ZS; Rozhdestvenskiĭ LM
    Radiobiologiia; 1986; 26(6):809-11. PubMed ID: 3468556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytogenetic analysis of bone marrow protection with mexamine in different radiation doses].
    Voĭtkevich ND; Palyga GF; Iarmonenko SP
    Med Radiol (Mosk); 1974 Nov; 19(11):12-7. PubMed ID: 4530889
    [No Abstract]   [Full Text] [Related]  

  • 18. [Problems in demonstrating protector-modified radioresistance. 2. The correlation of the hypoxic and radioprotective effects of 5-methoxytryptamine in its deferred administration before irradiation].
    Rozhdestvenskiĭ LM; Grozdov SP
    Radiobiologiia; 1979; 19(6):868-75. PubMed ID: 294595
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists.
    Shimada I; Maeno K; Kazuta K; Kubota H; Kimizuka T; Kimura Y; Hatanaka K; Naitou Y; Wanibuchi F; Sakamoto S; Tsukamoto S
    Bioorg Med Chem; 2008 Feb; 16(4):1966-82. PubMed ID: 18035544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The search for chemical compounds with potential radioprotective effects (review)].
    Vladimirov VG; Kostiukovskiĭ IaL; Slavachevskaia NM; Parfenov AI
    Farmakol Toksikol; 1972; 35(6):747-52. PubMed ID: 4569456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.